B O O K - American College of Rheumatology

ACR Poster Session A
154
101. Fibromyalgia Is Associated with a Disruption of Emotional
Modulation of Pain, but Not Emotional Modulation of Spinal
Nociception. Jennifer L. DelVentura 1 , Ellen L. Terry 2 , Emily J.
Bartley 2 , Ashley Vincent 2 , Ewa Olech 3 and Jamie L. Rhudy 2 ,
1
The University of Tulsa, Tulsa, OK, 2 The University of Tulsa,
3
University of Oklahoma, Health Sciences Center.
102. Fibromyalgia with and without Comorbid Positional Cervical
Cord Compression (PC3): An Iron-Clad Difference. Patrick B.
Wood 2 , Tobias Schmidt-Wilcke 3 and Andrew J. Holman 1 , 1 Pacific
Rheumatology Assoc, Renton, WA, 2 Pacific Rheumatology
Associates, Renton, WA, 3 University of Michigan.
103. Flt3-L Is a Novel Biomarker Increased in Cerebrospinal Fluid
of Patients with Primary Fibromyalgia and Sjogren Syndrome.
Jan L. Bjersing, Mats Dehlin, Henrik Zetterberg, Anette Larsson,
Malin Erlandsson, Kaisa Mannerkorpi and Maria Bokarewa, Dept
Rheumatology, Gothenburg University, Sweden.
104. Hysterectomy Status and Fibromyalgia Symptom Severity.
Mary O. Whipple, Ann Vincent, Terry H. Oh, Connie A. Luedtke
and Tanya L. Hoskin, Mayo Clinic, Rochester, MN.
105. Improvement in Multiple Dimensions of Fatigue in
Fibromyalgia Patients Treated with Duloxetine. Lesley M.
Arnold 2 , Fujun Wang 1 , Jonna Ahl 1 , Paula Gaynor 1 and Madelaine
Wohlreich 1 , 1 Lilly USA LLC, Indianapolis, IN, 2 Women’s Health
Research Program, Department of Psychiatry, University of
Cincinnati College of Medicine, Cincinnati, OH.
106. Novel Treatment of Tendinopathies with a Sulfated
Disaccharide of Hyaluronic Acid-Promising In Vitro Results.
Anna Torrent 1 , Ramon Ruhí 1 , Carlos Aláez 1 , Constanze
Buhrmann 2 and Mehdi Shakibaei 3 , 1 BIOIBERICA S.A., Palafolls,
Barcelona, Spain, 2 Ludwig-Maximilians-University, Munich,
Germany, 3 Ludwig-Maximilians-University Munich, Munich,
Germany.
107. Outcome for a Prospective Cohort of Fibromyalgia Patients
Receiving Tailored Treatments in a Multidisciplinary Pain
Center. Mary-Ann Fitzcharles, Pantelis Panopalis, Ann Gamsa,
Mark Ware and Yoram Shir, McGill University.
108. Predictors of Clinical Outcome in Fibromyalgia: Single Center
Experience of a Brief Interdisciplinary Fibromyalgia Treatment
Program. Terry H. Oh 1 , Tanya L. Hoskin 1 , Connie L. Luedtke 2 ,
Toby N. Weingarten 2 , Ann Vincent 2 and Jeffrey M. Thompson 2 ,
1
Mayo Clinic, Rochester, MN, 2 Mayo Clinic.
109. Should Rheumatologists Retain Ownership of Fibromyalgia?
A Survey of Ontario Rheumatologists. Sassan Ghazan-Shahi,
Tanveer E. Towheed and Wilma Hopman, Queen’s University,
Kingston, ON, Canada.
110. The Course of Fibromyalgia – A Long-Term Longitudinal Cohort
Study. Brian Walitt 5 , Winfried Häuser 3 , Afton Hassett 4 , Robert S.
Katz 2 and Frederick Wolfe 1 , 1 National Databank for Rheumatic
Diseases, 2 Rush University, 3 Technische Universität München,
4
University of Michigan Medical School, 5 Washington Hospital
Center, Washington, DC.
111. The Development of Fibromyalgia: Examination of Rates
and Predictors in Patients with Osteoarthritis (OA). Frederick
Wolfe 1 and Winfried Häuser 2 , 1 National Data Bank for Rheumatic
Diseases, Wichita, KS, 2 Technische Universität München,
Munich, Germany.
2010 Program Book
112. The Development of Fibromyalgia: Examination of Rates
and Predictors in Patients with Rheumatoid Arthritis (RA).
Frederick Wolfe 1 , Winfried Häuser 3 , Afton L. Hassett 4 , Robert
S. Katz 2 and Brian T. Walitt 5 , 1 National Data Bank for Rheumatic
Diseases, Wichita, KS, 2 Rush University Medical Center, Chicago,
IL, 3 Technische Universität München, 4 University of Michigan
Medical School, 5 Washington Hospital Center, Washington, DC.
113. The Effect of Duloxetine on Cognition in Patients with
Fibromyalgia. Philip J. Mease 3 , Lesley Arnold 4 , Fujun Wang 1 ,
Jonna Ahl 1 , Richard Mohs 1 , Paula Gaynor 1 and Madelaine
Wohlreich 2 , 1 Eli Lilly and Company, 2 Lilly USA, LLC, 3 Seattle
Rheumatology Associate, Seattle, WA, 4 Women’s Health
Research Program, Department of Psychiatry, University of
Cincinnati College of Medicine, Cincinnati, OH.
114. The Effectiveness of Botulinum Toxin Type-A and Prilocaine
Injections in Myofascial Pain Syndrome. Mehmet Zeki Kiralp,
Baki Ozdemir, Engin Cakar, Oguz Durmus, Levent Tekin and Umit
Dincer, Gülhane Military Medical Academy, Haydarpasa Training
Hospital, Department of Physical Medicine and Rehabilitation,
Istanbul, Turkey.
115. The Patient Specific Functional Scale Outperforms the
Fibromyalgia Impact Questionnaire Physical Function Scale.
Chad S. Boomershine 1 , Kim A. Edwards 2 , Jennifer Y. Hong 2 and
Kenneth A. Wallston 2 , 1 Vanderbilt University, Nashville, TN,
2
Vanderbilt University.
116. The Revised Version of the Fibromyalgia Impact Questionnaire:
Association with Physical Function and Quality of Life. Seong-
Rye Seo 1 , Sung-Ji Lee 3 , Tae-Jong Kim 3 , Yong-Wook Park 3 and
Shin-Seok Lee 2 , 1 Chonnam Natl Univ Med School, Gwangju,
Republic of Korea, 2 Chonnam Natl Univ Med School, Gwangju,
Korea, Republic of, 3 Chonnam Natl Univ Med School.
117. Treatment with FDA Approved Therapies in Patients with
Fibromyalgia. Brian T. Walitt 3 , Robert S. Katz 2 and Frederick
Wolfe 1 , 1 National Data Bank for Rheumatic Diseases, Wichita,
KS, 2 Rheumatology Associates, Chicago, IL, 3 Washington Hospital
Center, Washington, DC.
Imaging of Rheumatic Disease I: X-ray, CT and MRI
118. A Novel Tool for Fully Automatic Quantification of MRI
Synovitis in Rheumatoid Arthritis Is More Sensitive to Change
Than the Current Standard Semi-Quantitative Assessment.
Michael A. Bowes 1 , Jane E. Freeston 4 , Edward J. Vital 4 , Graham
Vincent 2 , Gwenael Guillard 2 , Paul Bird 5 , Paul Emery and Philip
G. Conaghan 4 , 1 Imorphics Ltd, Manchester, United Kingdom,
2
Imorphics Ltd, 4 Section of Musculoskeletal Disease, University
of Leeds, UK, 5 University of NSW, Sydney, Australia.
119. Application of High-Resolution Peripheral Quantitative
Computed Tomography (HR-pQCT) To Quantify Bony Damage
in Rheumatoid Arthritis. Cheryl C. M. Barnabe 1 , Liam Martin 1 ,
Steven K. Boyd 2 and Susan G. Barr 1 , 1 University of Calgary,
Calgary, AB, Canada, 2 University of Calgary.
120. Baseline CRP Predicts Early Improvement in Synovitis, Osteitis,
and Erosion on MRI in RA Patients Treated with Tocilizumab:
Results from the ACT-RAY MRI Substudy. Orrin M. Troum 6 ,
Charles G. Peterfy 4 , Jeffrey L. Kaine 3 , Carol Chung 1 , Andrew
Anisfeld 1 , Ewa Olech 2 and Philip G. Conaghan 5 , 1 Genentech,
a Member of the Roche Group, South San Francisco, CA,
2
Oklahoma University Health Sciences Center, Oklahoma City,
OK, 3 Sarasota Arthritis Research Center, Sarasota, FL, 4 Spire
Sciences and Synarc, San Francisco, Kentfield, CA, 5 University
of Leeds, Leeds, United Kingdom, 6 University of Southern
California, Santa Monica, CA, Santa Monica, CA.